Minervax is based in Frederiksberg, Denmark. It has raised $127M in total funding. Backed by EQT Life Sciences, OrbiMed, Novo Holdings.
Minervax funding overview
Minervax is based in Frederiksberg, Denmark. Minervax has raised $127M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Minervax runs through 2023; nothing later has been disclosed. Investors on record include EQT Life Sciences, OrbiMed, Novo Holdings, Pureos Ventures, Sanofi Ventures, Trill Impact Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Minervax at a glance
Total raised
$127M
Latest round date
October 2023
Headquarters
Frederiksberg, Denmark
Notable investors
EQT Life Sciences, OrbiMed, Novo Holdings, Pureos Ventures, Sanofi Ventures, Trill Impact Ventures, Adjuvant Capital, Wellington Partners
Frequently asked about Minervax funding
How much has Minervax raised?
Minervax has raised $127M in total disclosed funding across the rounds on record.
Who has invested in Minervax?
EQT Life Sciences, OrbiMed, Novo Holdings, Pureos Ventures, Sanofi Ventures, Trill Impact Ventures are named among the investors backing Minervax.
What was the latest Minervax funding round?
No round stage has been disclosed for Minervax.
Where is Minervax based?
Minervax is based in Frederiksberg, Denmark.
When did Minervax last raise?
The last disclosed Minervax round closed in October 2023.
Totals shown for Minervax aggregate every disclosed round on file. To see how that compares, browse the companies in Frederiksberg and the investors behind them below.
